Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry
Journal of Clinical Oncology - United States
doi 10.1200/jco.18.00210
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
American Society of Clinical Oncology (ASCO)